As capital efficiency is becoming increasingly important, venture capitalists are creating alternative investment vehicles to encourage portfolio companies to conserve capital and de-risk investments. In this panel we will discuss some of the models including increased focus on deal syndication, use of the Accelerator model to enhance management efficiency and partnerships with large pharmaceutical companies to enhance the chances of non-dilutive financings in the future.

• Accelerator Corp. enables companies and investors to be cash efficient
• Traditional venture capitalists are exploring new ways to de-risk investments
• Alternative venture capital financing vehicles are being developed